Genentech’s CEO Levinson Speaks; Company Gains FDA Approval for Avastin, Banks on Macular Degeneration Treatment

Genentech's Avasta has been approved. Today, Bloomberg interviewed the company's CEO. (Warning: the video skips)

BLOOM (BLOOM), National
Thu 12 Oct 2006 08:19 AM EDT
Today, Bloomberg interviewed Genentech's CEO, Arthur Levinson, for his views on the FDA approval.

On Tuesday, Bloomberg broadcast this report on the company.

BLOOM (BLOOM), National

Tue 10 Oct 2006 08:51 PM EDT